Cat.#: ACPP-1090
| Despition | PAX5 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1159 | Recombinant Mouse SIRP alpha Protein (6×His Tag) (AC1159) | 50 µg | inquiry |
| ACPP-1666 | Human LGALS3 Protein, His (AC1666) | 5 µg | inquiry |
| ACPP-1682 | Human CALB1 Protein (AC1682) | 10 µg | inquiry |
| ACPP-1393 | Human ALDH3A1 Protein (AC1393) | 2 µg | inquiry |
| ACPP-1006 | Recombinant Human TNF Receptor II Protein (6×His Tag) (AC1006) | 50 µg | inquiry |
| ACPP-1203 | ADCY8 Blocking Peptide (AC1203) | 250 µg | inquiry |
| ACPP-1673 | Human TIMM8A Protein (AC1673) | 5 µg | inquiry |
| ACPP-1145 | Recombinant Mouse CD34 Protein (Fc Tag) (AC1145) | 50 µg | inquiry |
| ACPP-1036 | Recombinant Human ANGPTL7 Protein (6×His Tag) (AC1036) | 50 µg | inquiry |
| ACPP-1604 | Human GSK3B Protein (AC1604) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.